China Conjugate Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Conjugate Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Conjugate Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Conjugate Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GlaxoSmithKline

    • Bavarian Nordi

    • Sinovac Biotech

    • Sanofi Pasteur

    • Emergent BioSolutions

    • Pfizer

    • Serum Institute of India

    • Johnson & Johnson

    • Daiichi Sankyo Company

    • CSL

    • Astellas Pharma

    • Fablife

    • SutroVax

    • Mitsubishi Tanabe Pharma

    • Merck

    • Medimmune

    By Type:

    • Monovalent

    • Multivalent

    By End-User:

    • Hospitals

    • Clinics

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Conjugate Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Conjugate Vaccine Market Size and Growth Rate of Monovalent from 2016 to 2027

    • 1.3.2 China Conjugate Vaccine Market Size and Growth Rate of Multivalent from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Conjugate Vaccine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Conjugate Vaccine Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Conjugate Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Conjugate Vaccine by Major Types

    • 3.4.1 Market Size and Growth Rate of Monovalent

    • 3.4.2 Market Size and Growth Rate of Multivalent

    4 Segmentation of Conjugate Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Conjugate Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Conjugate Vaccine in Hospitals

    • 4.4.2 Market Size and Growth Rate of Conjugate Vaccine in Clinics

    5 Market Analysis by Regions

    • 5.1 China Conjugate Vaccine Production Analysis by Regions

    • 5.2 China Conjugate Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Conjugate Vaccine Landscape Analysis

    • 6.1 North China Conjugate Vaccine Landscape Analysis by Major Types

    • 6.2 North China Conjugate Vaccine Landscape Analysis by Major End-Users

    7 Central China Conjugate Vaccine Landscape Analysis

    • 7.1 Central China Conjugate Vaccine Landscape Analysis by Major Types

    • 7.2 Central China Conjugate Vaccine Landscape Analysis by Major End-Users

    8 South China Conjugate Vaccine Landscape Analysis

    • 8.1 South China Conjugate Vaccine Landscape Analysis by Major Types

    • 8.2 South China Conjugate Vaccine Landscape Analysis by Major End-Users

    9 East China Conjugate Vaccine Landscape Analysis

    • 9.1 East China Conjugate Vaccine Landscape Analysis by Major Types

    • 9.2 East China Conjugate Vaccine Landscape Analysis by Major End-Users

    10 Northeast China Conjugate Vaccine Landscape Analysis

    • 10.1 Northeast China Conjugate Vaccine Landscape Analysis by Major Types

    • 10.2 Northeast China Conjugate Vaccine Landscape Analysis by Major End-Users

    11 Southwest China Conjugate Vaccine Landscape Analysis

    • 11.1 Southwest China Conjugate Vaccine Landscape Analysis by Major Types

    • 11.2 Southwest China Conjugate Vaccine Landscape Analysis by Major End-Users

    12 Northwest China Conjugate Vaccine Landscape Analysis

    • 12.1 Northwest China Conjugate Vaccine Landscape Analysis by Major Types

    • 12.2 Northwest China Conjugate Vaccine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 GlaxoSmithKline

      • 13.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Bavarian Nordi

      • 13.2.1 Bavarian Nordi Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sinovac Biotech

      • 13.3.1 Sinovac Biotech Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Sanofi Pasteur

      • 13.4.1 Sanofi Pasteur Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Emergent BioSolutions

      • 13.5.1 Emergent BioSolutions Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Pfizer

      • 13.6.1 Pfizer Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Serum Institute of India

      • 13.7.1 Serum Institute of India Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Johnson & Johnson

      • 13.8.1 Johnson & Johnson Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Daiichi Sankyo Company

      • 13.9.1 Daiichi Sankyo Company Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 CSL

      • 13.10.1 CSL Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Astellas Pharma

      • 13.11.1 Astellas Pharma Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Fablife

      • 13.12.1 Fablife Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 SutroVax

      • 13.13.1 SutroVax Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Mitsubishi Tanabe Pharma

      • 13.14.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Merck

      • 13.15.1 Merck Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Medimmune

      • 13.16.1 Medimmune Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Conjugate Vaccine Market Size and Growth Rate of Monovalent from 2016 to 2027

    • Figure China Conjugate Vaccine Market Size and Growth Rate of Multivalent from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Conjugate Vaccine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Conjugate Vaccine Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Conjugate Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Conjugate Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Conjugate Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Conjugate Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Conjugate Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Monovalent

    • Figure Market Size and Growth Rate of Multivalent

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Conjugate Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Conjugate Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Table China Conjugate Vaccine Production by Regions

    • Table China Conjugate Vaccine Production Share by Regions

    • Figure China Conjugate Vaccine Production Share by Regions in 2016

    • Figure China Conjugate Vaccine Production Share by Regions in 2021

    • Figure China Conjugate Vaccine Production Share by Regions in 2027

    • Table China Conjugate Vaccine Consumption by Regions

    • Table China Conjugate Vaccine Consumption Share by Regions

    • Figure China Conjugate Vaccine Consumption Share by Regions in 2016

    • Figure China Conjugate Vaccine Consumption Share by Regions in 2021

    • Figure China Conjugate Vaccine Consumption Share by Regions in 2027

    • Table North China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table North China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure North China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure North China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure North China Conjugate Vaccine Consumption Share by Types in 2027

    • Table North China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table North China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure North China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure North China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table Central China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table Central China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Central China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure Central China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure Central China Conjugate Vaccine Consumption Share by Types in 2027

    • Table Central China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table Central China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure Central China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure Central China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table South China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table South China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure South China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure South China Conjugate Vaccine Consumption Share by Types in 2027

    • Table South China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table South China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure South China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure South China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table East China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table East China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure East China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure East China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure East China Conjugate Vaccine Consumption Share by Types in 2027

    • Table East China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table East China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure East China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure East China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table Northeast China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure Northeast China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure Northeast China Conjugate Vaccine Consumption Share by Types in 2027

    • Table Northeast China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table Southwest China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table Southwest China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure Southwest China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure Southwest China Conjugate Vaccine Consumption Share by Types in 2027

    • Table Southwest China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure Southwest China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure Southwest China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table Northwest China Conjugate Vaccine Consumption by Types from 2016 to 2027

    • Table Northwest China Conjugate Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Conjugate Vaccine Consumption Share by Types in 2016

    • Figure Northwest China Conjugate Vaccine Consumption Share by Types in 2021

    • Figure Northwest China Conjugate Vaccine Consumption Share by Types in 2027

    • Table Northwest China Conjugate Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Conjugate Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Conjugate Vaccine Consumption Share by End-Users in 2016

    • Figure Northwest China Conjugate Vaccine Consumption Share by End-Users in 2021

    • Figure Northwest China Conjugate Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Bavarian Nordi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordi

    • Figure Sales and Growth Rate Analysis of Bavarian Nordi

    • Figure Revenue and Market Share Analysis of Bavarian Nordi

    • Table Product and Service Introduction of Bavarian Nordi

    • Table Company Profile and Development Status of Sinovac Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinovac Biotech

    • Figure Sales and Growth Rate Analysis of Sinovac Biotech

    • Figure Revenue and Market Share Analysis of Sinovac Biotech

    • Table Product and Service Introduction of Sinovac Biotech

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

    • Table Company Profile and Development Status of Emergent BioSolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions

    • Table Product and Service Introduction of Emergent BioSolutions

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Serum Institute of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

    • Figure Sales and Growth Rate Analysis of Serum Institute of India

    • Figure Revenue and Market Share Analysis of Serum Institute of India

    • Table Product and Service Introduction of Serum Institute of India

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Daiichi Sankyo Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Company

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Company

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Company

    • Table Product and Service Introduction of Daiichi Sankyo Company

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Fablife

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fablife

    • Figure Sales and Growth Rate Analysis of Fablife

    • Figure Revenue and Market Share Analysis of Fablife

    • Table Product and Service Introduction of Fablife

    • Table Company Profile and Development Status of SutroVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SutroVax

    • Figure Sales and Growth Rate Analysis of SutroVax

    • Figure Revenue and Market Share Analysis of SutroVax

    • Table Product and Service Introduction of SutroVax

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Medimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune

    • Figure Sales and Growth Rate Analysis of Medimmune

    • Figure Revenue and Market Share Analysis of Medimmune

    • Table Product and Service Introduction of Medimmune


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.